Cleared Traditional

K212975 - MedWand

K212975 is an FDA 510(k) clearance for MedWand, manufactured by Medwand Solutions, Inc.. The device is a Class 2 Cardiovascular device with product code MWI cleared through the Traditional 510(k) pathway after a 308-day FDA review.

K212975 · Medwand Solutions, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2022
Decision
308d
Days
Class 2
Risk

K212975 is an FDA 510(k) clearance for the MedWand. Classified as Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (product code MWI), Class II - Special Controls.

Submitted by Medwand Solutions, Inc. (Rancho Santa Margarita, US). The FDA issued a Cleared decision on July 22, 2022 after a review of 308 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Medwand Solutions, Inc. devices

FDA 510(k) Submission Details - K212975

510(k) Number K212975 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 17, 2021
Decision Date July 22, 2022
Days to Decision 308 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
183d slower than avg
Panel avg: 125d · This submission: 308d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MWI Device Classification - Class 2, Special Controls

Product Code MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

NJK & Associates, Inc.
Natalie J Kennel

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)

All 151
Devices cleared under the same product code (MWI) and FDA review panel - the closest regulatory comparables to K212975.
VS 8 Vital Signs Monitor, VS 8A Vital Signs Monitor, VS 9 Vital Signs Monitor
K221267 · Shenzhen Mindray Bio-Meidcal Electronics Co., Ltd. · Dec 2022
Accutorr 3 Vital Signs Monitor, Rosebud Vital Signs Monitor
K221113 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Dec 2022
Welch Allyn Connex Central Station
K212473 · Welch Allyn, Inc. · Oct 2022
Capsule Surveillance System
K213335 · Capsule Surveillance Technologies, Sas /Capsule Tech, Inc. · Jan 2022
Vital Signs Monitor
K211754 · Beijing Choice Electronic Technology Co., Ltd. · Nov 2021
Capsule Vitals Plus Patient Monitoring System
K210204 · Capsule Technologie Sas · Oct 2021